GVB Biopharma Acquisition

GVB COMPLETES 22ND CENTURY'S B2B CAPABILITIES 22nd Century will now offer the most robust platform to service the rapid growth of cannabinoid products # of Participants Plant Profile / Roadmap Canna Metrix CannaMetrix's high- throughput proprietary, human cell-based assay technology serves as a roadmap for developing new plant lines with tailor-made profiles. Few Plant Biotechnology Ke Gene Established proprietary bioinformatics platform and cutting-edge molecular breeding platform in partnership with KeyGene; capabilities include genetic engineering and plant line development. Dozens (Few are advanced) Plant Breeding & Trials Extractas Bioscience Multiple partnerships with top global breeders provide 22nd Century with both northern and southern hemisphere, indoor and outdoor, year-round plant breeding and trial capabilities. Few Plant Cultivation NEEDLE ROCK FARMS Colorado farm operations provide 22nd Century with operational assets including plant cultivation capabilities. Hundreds Ingredient Extraction, Purification, and Finished Products fo www WAAAAAA www. GVB) BIOPHARMA Hemp-derived active ingredients extractor and finished products manufacturer providing customers with bulk ingredients and white label products Dozens (Very few are reputable and with scale) 22ND CENTURY GROUP Commercial Partners 22nd Century offers an end-to-end, high-value add solution for leading nutraceutical, consumer products and pharmaceutical companies entering the ascendant cannabis market Thousands 9

View entire presentation